Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Jiangsu Feymer Technology Co., Ltd. (688350.SS)
Zhangjiagang, CN
Jiangsu Feymer Technology Co., Ltd. is a Chinese enterprise specializing in the manufacture and distribution of hydrophilic functional polymers. The company's diverse product portfolio features functional monomers, alongside a broad array of specialized chemicals designed for various industrial applications, including water and sludge purification, membrane technology, pulp and paper production, mineral processing, textile dyeing, and oil and gas extraction, among other industrial water treatment processes. Additionally, they provide membrane solutions for water treatment. Established in 2010, Jiangsu Feymer Technology Co., Ltd. conducts its operations from Zhangjiagang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.56% | -6.66% | +22.96% | +5.01% | +65.78% | +40.07% | +123.57% | +105.12% | +59.12% | +36.77% | +36.77% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Chemicals - Specialty: +4.7%-11.3% Q1'26: +7.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+425.0% ★ Q1'26: +275.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+4.8% ★ Q1'26: +4.1% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+1.5% Q1'26: +8.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+1.2% Q1'26: +6.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+2.2% Q1'26: -6.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×6.86× Q1'26: 3.55× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|
| Revenue |
1.70B
est: 1.70B (+0.0%)
|
1.64B
est: 1.58B (+3.7%)
|
1.57B
est: 1.76B (-11.2%)
|
1.39B
est: 2.20B (-36.8%)
|
2.61B
2.61B – 2.61B
+18.6% YoY
|
| EBITDA |
218.93M
est: 196.85M (+11.2%)
|
112.72M
est: 183.54M (-38.6%)
|
110.37M
est: 172.01M (-35.8%)
|
113.98M
est: 214.36M (-46.8%)
|
254.26M
254.26M – 254.26M
+18.6% YoY
|
| EBIT |
143.37M
est: 103.41M (+38.6%)
|
29.60M
est: 96.41M (-69.3%)
|
17.54M
est: 76.30M (-77.0%)
|
21.15M
est: 95.08M (-77.8%)
|
112.78M
112.78M – 112.78M
+18.6% YoY
|
| Net Income |
128.21M
est: 136.81M (-6.3%)
|
27.21M
est: 81.84M (-66.8%)
|
-4.65M
est: 28.53M (-116.3%)
|
15.21M
est: 39.23M (-61.2%)
|
43.98M
43.98M – 43.98M
+12.1% YoY
|
| SGA |
111.74M
est: 73.50M (+52.0%)
|
128.93M
est: 68.53M (+88.1%)
|
119.20M
est: 113.38M (+5.1%)
|
38.62M
est: 141.30M (-72.7%)
|
167.60M
167.60M – 167.60M
+18.6% YoY
|
| EPS |
1.04
est: 1.12 (-7.1%)
|
0.22
est: 0.67 (-67.2%)
|
-0.04
est: 0.24 (-116.7%)
|
0.13
est: 0.33 (-60.6%)
|
0.37
0.37 – 0.37
+12.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-28 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-27 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-26 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-29 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Guo Feng He | Deputy Director of Process R&D | — | male |
| Jiang Wen Han | GM & President | — | male |
| Li Feng Ma | Deputy General Manager of Fumiao Membrane Technology | — | female |
| Li Hua Wang | Accounting Supervisor | — | — |
| Ping Li | Deputy GM, Vice President & Director | — | male |
| Qin Wang | Technical Director | — | male |
| Wei Wang | Deputy General Manager of Fumiao Membrane Technology | — | male |
| Wu Jun Yan | Deputy Director of Application Technology | — | male |
| Yan Xing | Vice President, Deputy GM, Chief Financial Officer & Secretary of the Board | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 688350.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
